Xvivo Perfusion AB (publ) (STO: XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,080	10,379	5,459	8,215	9,018	4,522
Market Cap Growth	86.16%	90.12%	-33.55%	-8.90%	99.42%	29.75%
Enterprise Value	13,655	9,810	5,150	7,936	8,417	4,331
Last Close Price	447.00	329.50	183.00	278.50	314.00	170.00
PE Ratio	68.30	113.04	296.26	1007.77	-	915.59
Forward PE	83.24	199.33	111.93	211.39	288.07	130.60
PS Ratio	18.53	17.37	13.15	31.79	50.14	20.48
PB Ratio	6.76	5.34	3.82	6.39	8.94	7.83
P/TBV Ratio	11.03	7.84	6.86	10.06	11.59	8.95
P/FCF Ratio	-	3172.09	564.50	-	-	237.98
P/OCF Ratio	239.05	224.23	195.98	-	-	153.27
EV/Sales Ratio	18.19	16.42	12.40	30.71	46.80	19.61
EV/EBITDA Ratio	144.99	515.41	387.15	-	-	368.87
EV/EBIT Ratio	235.53	1818.08	1156.31	-	-	1090.62
EV/FCF Ratio	-28329.58	2998.27	532.54	-	-	227.92
Debt / Equity Ratio	0.01	0.02	0.01	0.00	0.01	0.01
Debt / EBITDA Ratio	0.26	1.06	0.51	-	-	0.37
Debt / FCF Ratio	-	9.61	1.03	-	-	0.29
Asset Turnover	0.33	0.30	0.25	0.19	0.20	0.36
Inventory Turnover	1.14	1.23	1.29	1.02	0.97	1.45
Quick Ratio	4.23	4.94	2.60	4.43	5.51	3.97
Current Ratio	5.49	6.14	3.47	5.24	6.41	4.94
Return on Equity (ROE)	10.18%	5.44%	1.36%	0.71%	-5.52%	0.88%
Return on Assets (ROA)	1.60%	0.17%	0.17%	-0.87%	-3.09%	0.41%
Return on Capital (ROIC)	1.78%	0.20%	0.20%	-1.02%	-3.45%	0.44%
Earnings Yield	1.46%	0.88%	0.34%	0.10%	-0.48%	0.11%
FCF Yield	-0.00%	0.03%	0.18%	-0.27%	-0.17%	0.42%
Buyback Yield / Dilution	-4.55%	-1.39%	-2.04%	-6.49%	-1.39%	-1.89%
Total Shareholder Return	-4.55%	-1.39%	-2.04%	-6.49%	-1.39%	-1.89%

Source: S&P Capital IQ. Standard template. Financial Sources.